Press release
With ~11% CAGR, Boost the Market Growth of Ursodeoxycholic Acid | ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH
"The global market for Ursodeoxycholic Acid was anticipated to grow from USD 432 million in 2020 to USD 1105 million by 2029; it is expected to grow at a CAGR of 11% during 2022 to 2029."Ursodeoxycholic acid (UDCA) is a medication used to treat gallstones and liver problems linked to cystic fibrosis. It alters the bile acid pool by reducing hydrophobic bile acids and increasing harmless hydrophilic ones, halting the progression from gastroesophageal varices to cirrhosis and increasing patients' long-term survival. UDCA therapy is particularly beneficial in patients with intrahepatic cholestasis of pregnancy, primary sclerosing cholangitis, nonalcoholic fatty liver disease, cystic fibrosis-associated liver disease, total parenteral nutrition-induced cholestasis, graft-related liver disease, and some pediatric cholestatic liver diseases.
Request for a free sample copy of this report-> https://exactitudeconsultancy.com/reports/3236/ursodeoxycholic-acid-market#request-a-sample
**Note - Updated Version 2023 is available
► Growth Drivers
Chronic cholestatic liver disorders are increasingly being treated with ursodeoxycholic acid. The primary driver fueling growth of the worldwide ursodeoxycholic acid market during the forecast period is the rising prevalence of cystic fibrosis and gallstones. Around 30,000 Americans had cystic fibrosis in 2015, according to data from the Cystic Fibrosis Foundation. Additionally, the US diagnoses about 1,000 new instances of cystic fibrosis each year.
Compared to men, women are more likely to acquire gallstones. The main causes of gallstone formation in women include high estrogen levels during pregnancy, birth control pills, or hormone replacement therapy.
However, issues like low efficacy (about 40%), sluggishness, and the potential for stone recurrence are anticipated to restrain market expansion.
► Restraints
"Side Effects of Utilizing Ursodeoxycholic Acid to Reduce Market Growth"
Despite being one of the most effective treatments for the majority of liver problems, using this acid continuously for a very long time might still have some negative consequences on the body. This element may reduce market expansion.
Ursodeoxycholic acid can result in a variety of issues, including bloody or cloudy urine, quicker heartbeat, severe nausea, stomach discomfort, skin rashes, body itching, frequent urination urges, excruciating bladder pain, and difficulties urinating. These issues may reduce the market's user base.
► Who are the major players in this industry?
ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhongshan belling, Dipharma Francis, Grindeks, Erregierre, Abil Chempharma, Biotavia Labs, ICE, and others.
► Recent Developments in Ursodeoxycholic Acid Market
Recent developments in Ursodeoxycholic Acid industry, even after market report release, support market trends outlined in analysis.
ICE Pharma Group (IPG) is a generic pharmaceutical company with its own Marketing Authorizations (MAs) and experienced operational teams who can manage the manufacturing process through to a final product release into the European market.
► What exactly does market segmentation cover?
Ursodeoxycholic Acid Market By Type, 2020-2029, (USD Million) (Kilotons)
» Synthetic USDA
» Extraction USDA
Ursodeoxycholic Acid Market By Application, 2020-2029, (USD Million) (Kilotons)
» Pharmacy
» Health Products
Ursodeoxycholic Acid Market By Region, 2020-2029, (USD Million) (Kilotons)
» North America
» Europe
» Asia Pacific
» South America
» Middle East And Africa
Important Countries In All Regions Are Covered.
► Regional Analysis of the Ursodeoxycholic Acid Market
The market development, current market trends, and some research methodologies are all covered in the Ursodeoxycholic Acid Industry research report. It draws attention to crucial aspects like product portfolios, software architectures, and production strategies that have a direct impact on the market. Our research shows that even minor changes to a product's qualities can have a big impact on the previously mentioned criteria.
► Table of Content:
1 Study Reporting
1.1 Ursodeoxycholic Acid Product
1.2 Key Segments in This Study
1.3 Key Companies Covered
1.4 Market by Type
1.4.1 Global Ursodeoxycholic Acid Market Size Growth Rate by Type
1.5 Market by Application
2 Executive Instantaneous
2.1 Global Ursodeoxycholic Acid Market Size
2.1.1 Global Ursodeoxycholic Acid Revenue
2.1.2 Global Ursodeoxycholic Acid Production
2.2 Ursodeoxycholic Acid Growth Rate (CAGR)
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio
2.3.2 Key Ursodeoxycholic Acid Manufacturers
2.3.2.1 Ursodeoxycholic Acid Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Ursodeoxycholic Acid Product Offered
2.3.2.3 Date of Manufacturers Enter into Ursodeoxycholic Acid Market
2.4 Key Trends for Ursodeoxycholic Acid Markets & Products
3 Market Size by Manufacturers
3.1 Ursodeoxycholic Acid Production by Manufacturers
3.2 Mergers & Acquisitions, Expansion Plans
4 Ursodeoxycholic Acid Production by Regions
4.1 Global Ursodeoxycholic Acid Production by Regions
4.1.1 Global Ursodeoxycholic Acid Production Market Share by Regions
4.1.2 Global Ursodeoxycholic Acid Revenue Market Share by Regions
4.2 United States
4.2.1 United States Ursodeoxycholic Acid Production
4.2.2 United States Ursodeoxycholic Acid Revenue
4.2.3 Key Players in United States
4.2.4 United States Ursodeoxycholic Acid Import & Export
4.3 Europe
4.3.1 Europe Ursodeoxycholic Acid Production
4.3.2 Europe Ursodeoxycholic Acid Revenue
5 Ursodeoxycholic Acid Consumption by Regions
5.1 Global Ursodeoxycholic Acid Consumption by Regions
5.1.1 Consumption by Regions
5.1.2 Consumption Market Share by Regions
5.2 North America
5.2.1 North America Consumption by Application
5.2.2 North America Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Consumption by Application
5.3.2 Europe Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Consumption by Application
5.4.2 Asia Pacific Consumption by Countries
5.5.1 Central & South America) Consumption by Application
5.5.2 Central & South America Consumption by Country
6 Market Size by Type
6.1 Production by Type
6.2 Revenue by Type
6.3 Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global Ursodeoxycholic Acid Breakdown Dada by Application
7.2.1 Global Ursodeoxycholic Acid Consumption by Application
7.2.2 Global Ursodeoxycholic Acid Consumption Market Share by Application
8 Manufacturers Profiles
9 Production Forecasts
9.1 Ursodeoxycholic Acid Production and Revenue Forecast
9.1.1 Global Ursodeoxycholic Acid Production Forecast
9.1.2 Global Ursodeoxycholic Acid Revenue Forecast
9.2 Ursodeoxycholic Acid Production and Revenue Forecast by Regions
9.2.1 Global Ursodeoxycholic Acid Revenue Forecast by Regions
9.2.2 Global Ursodeoxycholic Acid Production Forecast by Regions
9.3 Ursodeoxycholic Acid Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Ursodeoxycholic Acid Production Forecast by Type
9.4.2 Global Ursodeoxycholic Acid Revenue Forecast by Type
10 Consumption Forecast
10.1 Ursodeoxycholic Acid Consumption Forecast by Application
10.2 Ursodeoxycholic Acid Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Ursodeoxycholic Acid Consumption Forecast by Regions
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Ursodeoxycholic Acid Consumption Forecast by Regions
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Ursodeoxycholic Acid Consumption Forecast by Regions
10.5.2 China
10.5.3 Japan
10.5.4 South Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Ursodeoxycholic Acid Consumption Forecast by Regions
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Ursodeoxycholic Acid Consumption Forecast by Regions
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Ursodeoxycholic Acid Sales Channels
11.2.2 Ursodeoxycholic Acid Distributors
11.3 Ursodeoxycholic Acid Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Key Findings in the Global Ursodeoxycholic Acid Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Continue….
► Healthcare Trending Reports
https://www.openpr.com/news/3201061/business-process-automation-market-is-expected-to-progress
https://www.openpr.com/news/3201066/next-generation-sequencing-market-status-growth-trends
► Customization Service of the Report:
Exactitude Consultancy offers personalized reports tailored to your specific needs, with a sales team dedicated to ensuring you receive a report that meets your specific requirements.
► Research Methodology
The report is based on data analysis strategies by skilled data analysts. The research methodology involves collecting and analyzing information to provide significant market predictions. Interviews with market influencers make primary research relevant and practical. The secondary method provides a direct insight into demand and supply. Both primary and secondary data collection methods are used, along with publicly available sources like annual reports and white papers, to provide a comprehensive understanding of the market. The report offers precise data analysis and a comprehensive market tour.
Get a Sample Copy of the Ursodeoxycholic Acid Market
Research Report (Use Corporate mail id for quick response)-@ https://exactitudeconsultancy.com/reports/3236/ursodeoxycholic-acid-market#request-a-sample
Connect Us:
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release With ~11% CAGR, Boost the Market Growth of Ursodeoxycholic Acid | ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH here
News-ID: 3207824 • Views: …
More Releases from Exactitude Consultancy

Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at …
Introduction
Cell therapy has emerged as a transformative pillar of modern medicine, offering the potential to repair, replace, or regenerate damaged tissues and organs. From CAR-T cell therapies for oncology to stem cell therapies for regenerative medicine, the field is redefining treatment paradigms across oncology, neurology, cardiology, and rare diseases.
As clinical pipelines expand and more therapies achieve regulatory approval, demand for efficient and scalable cell therapy manufacturing has surged. Specialized technologies…

Despite safety concerns, adavosertib exhibits early antitumor activity in uterin …
Uterine serous carcinoma (USC) is a rare but highly aggressive subtype of endometrial cancer, accounting for less than 10% of endometrial cancer cases but contributing to a disproportionately high mortality rate. It is often diagnosed at advanced stages, making it difficult to treat with conventional methods.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72873
In recent years, the treatment landscape has expanded beyond chemotherapy and surgery to include targeted therapies,…

Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Imp …
Catheter-related bloodstream infections (CRBSIs) are among the most common and serious complications associated with intravascular catheters used in hospitals and long-term care settings. These infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. With the rising use of central venous catheters, particularly among critically ill patients, oncology cases, and those requiring long-term intravenous therapy, the global demand for effective prevention and treatment solutions is growing…

ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
Introduction
Antibody-drug conjugates (ADCs) represent one of the most innovative breakthroughs in oncology, combining the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. By delivering highly toxic payloads directly to cancer cells, ADCs minimize systemic toxicity and enhance therapeutic efficacy.
As cancer incidence rises worldwide and the limitations of conventional chemotherapy become more evident, ADC technology is gaining momentum. With advancements in linker chemistry, payload design, and next-generation…
More Releases for Ursodeoxycholic
Oral Ursodeoxycholic Acid Market New Product Development & Latest Trends
The global oral ursodeoxycholic acid market is valued at approximately $850 million in 2024. Forecasts indicate a robust growth trajectory, anticipating a market value of around $1.5 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of 6.4% from 2025 to 2034.
Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Oral Ursodeoxycholic Acid market…
Ursodeoxycholic Acid Market to see Booming Business Sentiments
The latest study released on the Global Ursodeoxycholic Acid Market by USD Analytics Research evaluates market size, trend, and forecast to 2030. The Ursodeoxycholic Acid market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players…
Ursodeoxycholic Acid API Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Ursodeoxycholic Acid API analysis, which studies the Electrical Cord Reels's industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Ursodeoxycholic Acid API 2020-2025” Research Report categorizes the global Ursodeoxycholic Acid API by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share,…
Ursodeoxycholic Acid Market Trends and Dynamic 2025 | Arcelor Chemicals
Global Ursodeoxycholic Acid Market: Overview
Ursodeoxycholic acid (UDCA) is essentially bile acid ingested in the liquid form or in the form of a tablet to cure gallstones. Those can cure or thwart the progress of cystic fibrosis-related liver disorder. UDCA transforms the bile acid pool by lowering the levels of hydrophobic bile acids. This increases the amount of nontoxic hydrophilic bile acids. Besides, UDCA can slow down the development of gastroesophageal…
Global Ursodeoxycholic Acid Industry Market Analysis & Forecast 2018-2023
Global Ursodeoxycholic Acid Industry has been utilized in the administration of puppies with incessant hepatitis and felines with lymphocytic plasmacytic cholangitis. It is accepted to be most useful in scatters where bile poisonous quality assumes an imperative job in the continuous pathology. The adequacy of Global Ursodeoxycholic Acid Industry in veterinary patients has not been certainly settled, in spite of the fact that reports recommend it might have some advantage…
Ursodeoxycholic Acid Market- ICE, Grindeks, Mitsubishi, Daewoong chemical, Pharm …
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. And the CAS number…